CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

Home About CADTH What We Do Programs and Services Drug Reimbursement Review Voriconazole

Voriconazole

Last Updated: August 24, 2004

Result type: Reports

Project Number: S0020

Product Line: Reimbursement Review

Generic Name: Voriconazole

Brand Name: VFEND

Manufacturer: Pfizer Canada Inc.

Indications: Aspergillosis, Invasive

Submission Type: Initial

Project Status: Withdrawn

Voriconazole

Files